Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review

Greater understanding of the underlying etiology and biology of breast cancer is enabling the clinical development of targeted therapies for metastatic breast cancer (MBC). Following the successful introduction of trastuzumab, the first human epidermal growth factor receptor (HER) biologically targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Lee S., Ashurst, Helen Louise, Chap, Linnea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Academia–Pharma Intersect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227950/
https://www.ncbi.nlm.nih.gov/pubmed/20200040
http://dx.doi.org/10.1634/theoncologist.2009-0145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227950/
https://www.ncbi.nlm.nih.gov/pubmed/20200040
http://dx.doi.org/10.1634/theoncologist.2009-0145

Ejemplares similares